Figure 3.

Expressions of FASLG and ICOSLG. (A) NPX values at T₀. (B) Correlation between FASLG and ICOSLG NPX values at T₀. The dotted lines represent the 95% confidence interval. (C) Dynamics in FASLG expression during the initial weeks of treatment. (D) Dynamics in ICOSLG expression during the initial weeks of treatment. FASLG, Fas ligand; ICOSLG, inducible T-cell co-stimulator ligand; NPX, normalized protein expression; T₀, pre-treatment; T₁, after one cycle of therapy; T₂, after two cycles of therapy; ns, not significant; *, p < 0.05; ***, p < 0.001.